We found for Filter results by Theme Select the product option you would like to filter Theme Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making Topic Select the product option you would like to filter Topic Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing Tag Select the product option you would like to filter Tag Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar Date 1 Select the product option you would like to filter Date Clear Filter Date From Month From Year From Date To Month To Year To January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 Author Select the product option you would like to filter Author Search authors Edwine Barasa Angela Kairu Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Content Type Select the product option you would like to filter Content Type news story insight events podcast bulletin publications Reset Filters Insight May 2025 GLP-1 Receptor Agonists: Shifting Obesity Management Read more Health Technology Assessment… Measuring and Valuing Outcomes Societal preferences Understanding societal preferences for priority by disease severity in England & Wales Read more Insight April 2024 Kahneman’s legacy in health economics Read more Insight March 2022 NICE’s severity modifier: a step in the right direction, but still a long way to go Read more Insight March 2022 Including Carer Quality of Life in Health Technology Evaluation: Are We There Yet? Read more Measuring and Valuing Outcomes When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies Read more Health Technology Assessment… Measuring and Valuing Outcomes How is Quality of Life Measured for Health Technology Assessments? Read more Health Care Systems Policy, Organisation and… Economic Evaluation Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments? Read more Value, Affordability, and… Cancer Using QALYs in Cancer: Review of the Methodological Limitations Read more Health Technology Assessment… Value, Affordability, and… Cancer Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience Read more Real World Evidence (RWE) Measuring and Valuing Outcomes Economic Post-Launch Studies: Matching the Desirable with the Feasible Read more Health Care Systems Policy, Organisation and… Clinical Outcomes To Publish or Not: Experience and Evidence About Publishing Hospital Outcomes Data Read more Health Care Systems Policy, Organisation and… Healthcare Delivery Influencing Prescribing in a Primary Care Led NHS Read more Health Care Systems Economics of Innovation Healthcare Delivery Disease Management, the NHS and the Pharmaceutical Industry Read more The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way Read more
Health Technology Assessment… Measuring and Valuing Outcomes Societal preferences Understanding societal preferences for priority by disease severity in England & Wales Read more
Insight March 2022 NICE’s severity modifier: a step in the right direction, but still a long way to go Read more
Insight March 2022 Including Carer Quality of Life in Health Technology Evaluation: Are We There Yet? Read more
Measuring and Valuing Outcomes When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies Read more
Health Technology Assessment… Measuring and Valuing Outcomes How is Quality of Life Measured for Health Technology Assessments? Read more
Health Care Systems Policy, Organisation and… Economic Evaluation Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments? Read more
Value, Affordability, and… Cancer Using QALYs in Cancer: Review of the Methodological Limitations Read more
Health Technology Assessment… Value, Affordability, and… Cancer Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience Read more
Real World Evidence (RWE) Measuring and Valuing Outcomes Economic Post-Launch Studies: Matching the Desirable with the Feasible Read more
Health Care Systems Policy, Organisation and… Clinical Outcomes To Publish or Not: Experience and Evidence About Publishing Hospital Outcomes Data Read more
Health Care Systems Policy, Organisation and… Healthcare Delivery Influencing Prescribing in a Primary Care Led NHS Read more
Health Care Systems Economics of Innovation Healthcare Delivery Disease Management, the NHS and the Pharmaceutical Industry Read more